Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Changes to the Board of Directors

Ayima Group AB today announces that the board member Björn Mannerqvist is resigning from Ayima's Board of Directors at his own request effective immediately. He is resigning for personal reasons. "I would like to take this opportunity to thank Björn for the contribution he has made during his time on Ayima's board," says Mike Nott, Chairman of the Board. Mike Jacobson, Tim Webb and Mike Nott are the remaining board members until a new independent representation can be elected.

Report from Annual General Meeting of Vitrolife AB (publ)

At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: · Resolution in accordance with the Board’s proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the record day. · Re-election of Board members Henrik Blomquist, Lars Holmqvist, Pia Marions, Jón Sigurdsson and Karen Lykke Sørensen, in accordance with the election committee’s proposal. Jón Sigurdsson was elected Chairman of the Board. · Remuneration to the Board members is proposed to be in total SEK 3,300,000 of which SEK 1,200,

ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm

On 4 April 2024, ADDvise Group AB (publ) (“ADDvise”) issued senior secured bonds in an amount of USD 60 million, under a total framework of USD 200 million (the “Bonds”). Pursuant to the terms and conditions for the Bonds, ADDvise has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For this purpose, the company has prepared a listing prospectus, which today has been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The prospectus is available at the company’s website www.addvisegroup.com and at the

Lytix Biopharma AS – Mandatory notification of trade by Primary Insiders and close associates

Oslo, Norway, 25 April 2024: Reference is made to the stock exchange announcements published by Lytix Biopharma AS ("Lytix" or the "Company") earlier today, on 25 April 2024, regarding the final results of the partially guaranteed share offering (the "Offering").   As of this date, the Company has been informed that the following primary insiders and close associates to primary insiders have been allocated new shares in the Offering, as set out below:   Hifo Invest AS, a close associate to primary insider, Brynjar Forbergsskog, subscribed for 724,448.00 shares in the Offering.

Resolutions at Eastnine’s Annual General Meeting 2024

Annual General Meeting (AGM) in Eastnine AB (publ) was held on Thursday 25 April 2024. At the AGM, decisions were made on e.g. dividend, Board, amendment of the articles of association, resolution regarding authorization for the Board of Directors to resolve on transfer, acquisition and new issue of shares. Furthermore it was resolved on a share split and to establish an incentive programme. The most important decisions are summarised below.Resolution of the AGM (in summary): Adoption of the income statements, balance sheets and dividend The AGM adopted the 2023 income statement and

Bulletin from the Annual General Meeting on April 25, 2024 in Electrolux Professional AB (publ)

Electrolux Professional's Annual General Meeting was held on April 25, 2024. The shareholders were also able to exercise their voting rights by postal voting in accordance with the provisions of Electrolux Professional’s Articles of Association.Income statements and balance sheets, dispositions in respect of the Company’s profit in accordance with the adopted balance sheet and discharge of liabilityThe parent company’s and the Group’s income statements and balance sheets were adopted. The Annual General Meeting resolved on a dividend of SEK 0.80 per share and that the retained earnings

Communiqué from the Annual General Meeting 2024 of Cell Impact AB (publ)

The annual general meeting of Cell Impact AB (publ) was held on 25 April 2024.Adoption of the profit and loss account and balance sheet as well as profit allocationThe annual general meeting approved the balance sheets and income statements included in the annual report for the financial year 2023 and resolved, in accordance with the proposal of the board of directors, that available profits of SEK 224,834,136 should be carried forward. Board of directors and auditorThe annual general meeting granted the directors of the board and the CEO discharge from liability for the financial

Hemnet utilises share buy-back authorisation

The board of directors of Hemnet Group AB (publ) ("Hemnet") has resolved to utilise the authorisation granted by the annual general meeting held on 25 April 2024 to repurchase Hemnet's own shares in order to adjust Hemnet's capital structure.   Acquisitions of shares pursuant to the share buy-back program will be carried out in accordance with the EU Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). Acquisitions of shares will be managed by an investment firm or credit institution that makes its

Change in the nomination committee's proposal regarding election of board members of Bio-Works

The Nomination Committee's proposal for the election of board members was reported in the notice for Bio-Works' Annual General Meeting, which was announced via a press release on April 23, 2024. Johan Sedihn has since informed that he has declined re-election at the Annual General Meeting. The Nomination Committee has now informed the company that it has decided to supplement the proposal with the nomination of an additional member, Thomas Gür.Thomas Gür was born in 1959 and has over 40 years of experience in the areas of communication, investor relations, media handling, and public

LKAB’s Annual General Meeting 2024

LKAB's Annual General Meeting was held 25 April 2024 at Vetenskapens Hus in Luleå. The AGM decided that a dividend of 7.6 billion kronor would be paid to the owner. Anders Borg was elected Chairman of the Board, succeeding Göran Persson, who steps down after seven years as chairman. Carina Andersson and Alrik Danielson were elected new board members.The AGM decided that a dividend of 7.6 billion kronor, corresponding to 10, 857 kronor per share, would be paid to the owner for the 2023 financial year. The AGM granted the board members and President discharge from liability for the 2023

Lytix Biopharma AS – Minutes of extraordinary general meeting and final results of share offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Oslo, Norway, 25 April 2024: Reference is made to the stock exchange announcements published by Lytix Biopharma AS ("Lytix" or the "Company") on 24 April 2024, regarding the results of a partially guaranteed share offering (the "

Lea bank ASA – Stena Adactum AB has purchased 1,5 million shares – private placement cancelled

Reference is made to the stock exchange notice of 22.12.2023 regarding Lea bank ASA enters into strategic partnership with Stena AB and acquires its consumer credit business. Initially the parties agreed that Stena Adactum AB would subscribe for 1.5 million shares in Lea bank ASA through a private placement. Stena Adactum AB has today notified Lea bank ASA that they have purchased 1,5 million shares in the market. The parties have therefore agreed to cancel the private placement of shares. We are excited to have Stena Group onboard as a shareholder and look forward to future

Report from Annual General Meeting in SaltX Technology Holding AB (publ)

At the Annual General Meeting in SaltX Technology Holding AB (publ) (the “company”) held on 25 April 2024, the following resolutions were passed. All resolutions were in accordance with the proposals, described in detail in the general meeting documents which are available at the company’s website, www.saltxtechnology.com. Adoption of the income statement and balance sheetIt was resolved to adopt the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet for 2023. Resolution on dispositions in respect of the company’s result

New shares of Nanoform registered with the trade register

Company Release Nanoform Finland Plc April 25, 2024 17.00 Finnish time / 16.00 Swedish time New shares of Nanoform registered with the trade register NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Nanoform Finland Plc ("Nanoform" or the "Company"), an innovative nanoparticle medicine enabling company, announced on April 24, 2024 the result of the offering of new

Alisa Pankki Oyj - Managers' Transactions - Pohjola

ALISA BANK PLC MANAGER TRANSACTIONS 25.4.2024 AT 16:45 EESTPerson subject to the notification requirementName: Markku PohjolaPosition: Member of the Board/Deputy memberIssuer: Alisa Pankki OyjLEI: 743700VK1NB8HRGTQH74Notification type: INITIAL NOTIFICATIONReference number: 59757/7/4 Transaction date: 2024-04-24Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000170915Nature of transaction: ACQUISITION (X) Executed under portfolio or asset management Transaction details(1): Volume: 25000 Unit price: 0.2 EUR  Aggregated transactions (1):

Attana enters the third year of a five-year service and support contract with a leading health institute in the US

The contract is now entering its third year and it is an important part of the company's plan to establish strong reference customers in the US. During the past year, several users have been trained in Attana's technology, and studies of T-cell interactions with animal cancer cells are currently being performed. The intention is that the data from the experiments will be published at the end of this year and that the project will then also be carried out on tumor tissues from biopsies. The institute is an important part in establishing strong reference customers in the USA. The projects

Change in KONE Corporation's holding of treasury shares

KONE Corporation, stock exchange release, April 25, 2024 at 4:40 p.m. EEST Change in KONE Corporation's holding of treasury shares KONE Corporation has assigned a total of 9,027 KONE class B shares to the members of KONE Corporation's Board of Directors as a part of the board members' annual remuneration according to the decision of the Annual General Meeting on February 29, 2024. The handover date for the shares was April 25, 2024. After the transfer, KONE Corporation holds 11,869,230 of its own class B shares. For further information, please contact:Sanna Kaje, Vice

Major shareholder announcement

Aquaporin A/S, Nymøllevej 78, DK-2800 Kongens Lyngby, aquaporin.com, Company registration no.: DK28315694 Company announcementNo. 11/2024 Copenhagen, Denmark, April 25, 2024 – Pursuant to section 38(1) of the Danish Capital Markets Act, Aquaporin A/S (ticker: AQP) (“Aquaporin” or the “Company”) hereby notifies receipt of major shareholder notification. Aquaporin has received notification that as a result of the results of the rights issue (as announced by Aquaporin in a company announcement published on April 25, 2024), VP Capital N.V.’s (“VP”) shareholding in Aquaporin is a

Discretionary additional capital requirement (Pillar 2) for Alisa Bank

ALISA BANK PLC STOCK EXCHANGE RELASE 25.4.2024 AT 16:30 EESTThe Finnish Financial Supervisory Authority has imposed on 24th April 2024 a discretionary additional capital requirement (Pillar 2) under chapter 11, section 6, section 6 a, subsection 1, paragraph 1 and section 6 b, subsection 1, paragraph 1 and 2 of the Act on Credit institutions (610/2014) for Alisa Bank Plc. The Pillar 2 requirement is 2.25% and must be covered as follows: at least three quarters of the additional capital requirement shall be Tier 1 capital, of which at least three quarters shall be Common Equity Tier 1

Obtained noteholder consents in respect of the EUR 300 million notes due 2025 not becoming effective due to the discontinuation of Tietoevry’s demerger process

Tietoevry Corporation  STOCK EXCHANGE RELEASE     25 April 2024   4:30 p.m. EEST Tietoevry announced on 21 March 2024 that it has received the required consents from the noteholders of its outstanding EUR 300 million senior unsecured notes due June 2025 in accordance with the terms and conditions set out in the notice of the noteholders' meeting dated 5 March 2024. Consents were solicited to enable the separation of Tietoevry's Banking business through a partial demerger. The obtained consents and waivers sanctioned by the noteholders in relation to the proposal and the payment of the

Sanolium publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm

Sanolium AB (publ) (the "Company" or "Sanolium") has issued a senior secured bond loan of SEK 1,000,000,000 on 15 March 2024, within a total framework amount of SEK 1,500,000,000, on the Swedish bond market (the "Bonds"). The Bonds carry a floating interest rate of STIBOR 3m + 4.00 per cent. per annum and matures 15 March 2029. The Company will apply for listing of the Bonds on the Corporate Bond list at Nasdaq Stockholm. The Bonds will be admitted to trading at Nasdaq Stockholm as soon as possible. In connection with this, the Company has prepared a prospectus. The prospectus has

On 24 April 2024, Nurminen Logistics Plc’s board of directors has decided, with the authorization of the annual general meeting, to pay an equity repayment of EUR 0.02 per share

Nurminen Logistics Plc      Stock Exchange Release April 25, 2024, at 4.15 pm On April 24, 2024, Nurminen Logistics Plc's board of directors, with the authorization of the annual general meeting, has decided to pay an equity repayment of EUR 0.02 per share for each of the company's 78,127,855 outstanding shares, i.e. a total of EUR 1,562,557.10. The equity repayment ex-date for the installment shall be 25 April 2024, the record date shall be 26 April 2024, and the equity repayment date shall be 3 May 2024. Nurminen Logistics Plc For more information, please contact Olli Pohjanvirta,

Committees of Metso’s Board of Directors

Metso Corporation’s stock exchange release on April 25, 2024, at 4:05 p.m. EESTThe Board of Directors of Metso Corporation held its organizing meeting after the Annual General Meeting held earlier today. In the organizing meeting, the Board of Directors elected the members of the Audit & Risk Committee and the Remuneration & HR Committee from among its members. Arja Talma was reappointed as Chair of the Audit & Risk Committee and Klaus Cawén, Terhi Koipijärvi, Ian W. Pearce and Emanuela Speranza as its members. Reima Rytsölä was reappointed as Chair of the Remuneration & HR

There are no items matching the current filter
There are no more items matching the current filter
Back to top